Effect of Infliximab on Chronic Progressive Behcet's Disease: Influence of the Timing of Introduction on the Patient Outcome-Reference-Cited by-同舟云学术

Effect of Infliximab on Chronic Progressive Behcet's Disease: Influence of the Timing of Introduction on the Patient Outcome

Author:

Hirohata Shunsei¹,Kikuchi Hirotoshi²,Sawada Tetsuji³,Kuwana Masataka⁴,Kawachi Izumi⁵,Kirino Yohei⁶,Ishigatsubo Yoshiaki⁷,Takeno Mitsuhiro⁸

Affiliation:

1. Department of Rheumatology, Nobuhara Hospital, Japan

2. Department of Internal Medicine, Teikyo University School of Medicine, Japan

3. Department of Rheumatology, Tokyo Medical University, Japan

4. Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Japan

5. Comprehensive Medical Education Center, Niigata University School of Medicine, Japan

6. Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Japan

7. Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Japan

8. Japan Department of Allergy and Rheumatology, Nippon Medical University Musashi Kosugi Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

Reference20 articles.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Behçet's syndrome;The Lancet;2024-03